Ingestion of silver nanoparticles leads to changes in blood parameters

Authors

1 Department of microbiology, Islamic Azad University, qom branch, qom, iran

2 Jahad daneshgahi, qom branch, qom, Iran

Abstract

Objective(s):
The silver nanoparticles, being very small size, can permeate the cellular membrane and interfere in the cell’s natural process. In the present study, the effects of time, the dosage of these particles and their use on blood molecules and hormones, the volume of drinking water, and the urine parameters were analyzed.
Materials and Methods:
Thirty six rats of the Wistar race, as subjects, were divided into six groups (one control group: C and five test groups: T1-T5). In the test groups, drinking water was replaced by the Nanosilver (NS) solution with concentrations of 5, 20, 35, 65, 95ppm. After three and six months, three rats were chosen randomly from each group, and their blood was collected.  Various blood parameters were measured instantly, and the results were processed by one-way analyses of variance and Tukey's test.

Results:
The animal’s uptake of water increased significantly in parallel with the increasing of the particles’ concentration. Ketone bodies were noticed to be present in the urine of the female rats received high doses of the particles. The level of T4 decreased considerably (p<0.05) in parallel with the time and the concentration of the received particles. Depending on the dosage, and the time of use, blood testosterone increased, and the level of blood cortisol decreased. The observed effects were more evident in the proceedings with the concentration of 35ppm.

Conclusion:
Ingestion of NS particles, especially by high doses and in long terms, can cause high blood pressure, tissue injury–particularly liver injury–and endocrine glands.

Keywords


  1. Chen D, Xi T, Bai J. Biological effects induced by nanosilver particles: in vivo study. 2007; Biomed Mater. 2(3): S126-128.
  2. Oberdörster G, Stone V, Donaldson K. Toxicology of nanoparticles: a historical perspective. 2007; Nanotoxicology.  1(1): 2-25.
  3. Ahari H. et al., Nanotechnology in medicine and veterinary medicine, JAHAD DANESHGAHI Pub., 1387-2009, [Text in Persian]
  4. Chen X, Schluesener HJ. Nanosilver: a nanoproduct in medical application. 2008; Toxicol Lett. 176(1): 1-12.
  5. Choi O, Deng KK, Kim NJ, Ross L, Surampalli RY, Hu Z. The inhibitory effects of silver nanoparticles, silver ions, and silver chloride colloids on microbial growth. 2008; Water Res. 42(12): 3066-3074.
  6. Arora S, Jain J, Rajwade JM, Paknikar KM. Interactions of silver nanoparticles with primary mouse fibroblasts and liver cells. 2009; Toxicol Appl Pharmacol. 236(3): 310-318.
  7. Hung HS, Hsu SH. Biological performances of poly(ether)urethane–silver nanocomposites. 2007; Nanotechnology. 18 475101. doi: 10.1088/0957-4484/18/47/475101.
  8. Kvitek L, Vanickova M, Panacek A, Soukupova J, Dittrich M, Valentova E, et al. Initial study on the toxicity of silver nanoparticles (NPs) against Paramecium caudatum. 2009; J Phys Chem. C. 113(11): 4296-4300.
  9. Hussain SM, Schlager JJ. Safety evaluation of silver nanoparticles: inhalation model for Chronic Exposure. 2009; Toxicol Sci. 108(2): 223-224.
  10. Babu K, Deepa M, Shankar S, Rai S. Effect of nano-silver on cell division and mitotic chromosomes: a prefatory siren. 2008;Inter J Nanotechnol. 2(2): 25-29.
  11. AshaRani PV, Low Kah Mun G, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. 2009; ACS Nano. 3(2): 279-290.
  12. Hussain S. M., Hess, K.L., Gearhart, J.M., Geiss, K.T., Schlager, J.J. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol. In Vitro. 2005; 19:975–983.
  13. Sung JH, Ji JH, Yoon JU, Kim DS, Song MY, Jeong J, et al. Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles. 2008; Inhal Toxicol. 20(6): 567-574.
  14. Cha K, Hong HW, Choi YG, Lee MJ, Park JH, Chae HK, et al. Comparison of acute responses of mice livers to short-term exposure to nano-sized or micro-sized silver particles. 2008; Biotechnol Lett. 30(11): 1893-1899.
  15. Korani M, Rezayat Sorkhabady M, Gilani K. Guinea pig Liver histopathologic investigation in nanosilver chronic dermal exposure. 2nd nanotechnology congress. 2007: http://www.EChemica.com/Paper-NANOSC02-NANOSC02_037.html
  16. Hsin YH, Chen CF, Huang S, Shih TS, Lai PS, Chueh PJ. The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. 2008; Toxicol Lett. 179(3): 130-139.
  17. Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann MC. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. 2005; Toxicol Sci. 88(2), 412-419.
  18. Singh SK, Goswami K, Sharma RD, Reddy MV, Dash D. Novel microfilaricidal activity of nanosilver. 2012; Int J Nanomedicine. 7: 1023-1030.
  19. Shahbazzadeh D, Ahar H, Mohammad Rahimi N, Dastmalchi F, Soltani M. The Effects of Nanosilver (Nanocid®) on Survival Percentage of Rainbow Trout (Oncorhynchus mykiss). 2009; Pakistan Journal of Nutrition. 8: 1178-1179.
  20. Bilberg K, Hovgaard MB, Besenbacher F, Baatrup E. In vivo toxicity of silver nanoparticles and silver ions in Zebrafish (Danio rerio). 2012; J Toxicol. 293784, doi:10.1155/2012/293784.
  21. Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, et al. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. 2008: Inhal Toxicol. 20(6): 575-583.